Mera Pharmaceuticals, Inc.
MRPI
$0.00
$0.000.00%
| 10/31/2011 | 07/31/2011 | 04/30/2011 | 01/31/2011 | 10/31/2010 | |
|---|---|---|---|---|---|
| Net Income | 65.09% | -97.05% | -78.70% | -198.33% | -178.99% |
| Total Depreciation and Amortization | -70.25% | -71.67% | -60.19% | -60.77% | -67.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.81% | 1,441.18% | 1,441.18% | 1,441.18% | 1,441.18% |
| Change in Net Operating Assets | -47.57% | -95.25% | -87.51% | 211.85% | 232.63% |
| Cash from Operations | -945.88% | -204.59% | -381.25% | 135.21% | 132.08% |
| Capital Expenditure | 98.47% | 98.40% | 98.41% | -493.63% | -522.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 98.47% | 98.40% | 98.23% | -1,279.63% | -1,556.31% |
| Total Debt Issued | -49.76% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -49.76% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -160.71% | 127.93% | 97.47% | 112.53% | 117.28% |
